Diphtheria, Tetanus, and Pertussis (DTaP)
GPTKB entity
Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
children
|
| gptkbp:alternativeVaccine |
gptkb:Tdap
gptkb:Td DT |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:boosterRecommended |
yes
|
| gptkbp:broadcastOn |
5 doses
|
| gptkbp:combinationVaccine |
yes
|
| gptkbp:contains |
inactivated toxins
acellular pertussis components |
| gptkbp:containsPreservative |
may contain aluminum salts
|
| gptkbp:contraindication |
severe allergic reaction to previous dose
|
| gptkbp:developedBy |
late 1990s
|
| gptkbp:firstDoseAge |
2 months
|
| https://www.w3.org/2000/01/rdf-schema#label |
Diphtheria, Tetanus, and Pertussis (DTaP)
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:protectedBy |
diphtheria
tetanus pertussis |
| gptkbp:recommendation |
gptkb:CDC
|
| gptkbp:replacedBy |
gptkb:DTP_vaccine
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
swelling at injection site redness at injection site mild fussiness |
| gptkbp:storage |
2-8°C
|
| gptkbp:WHOStatus |
yes
|
| gptkbp:bfsParent |
gptkb:United_States_(routine_vaccination)
|
| gptkbp:bfsLayer |
7
|